Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2019 April;154(2) > Giornale Italiano di Dermatologia e Venereologia 2019 April;154(2):186-91

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   

Giornale Italiano di Dermatologia e Venereologia 2019 April;154(2):186-91

DOI: 10.23736/S0392-0488.17.05773-X

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

MiR-564 promotes hypertrophic scar formation through TGF-β1 upregulation

Long XIAO 1, Tianyi TANG 1, Yu HUANG 2, Jianxing GUO 1

1 Department of Orthopedics, Zhangjiagang Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Zhangjiagang, China; 2 Department of Obstetrics and Gynecology, Zhangjiagang First People’s Hospital, Zhangjiagang Affiliated Hospital of Soochow University, Zhangjiagang, China


PDF


BACKGROUND: To evaluate the role of microRNA564 (miR-564) in the development of hypertrophic scar and investigate the possible mechanism of this process.
METHODS: The hypertrophic scar (HS) tissues and adjacent normal skin (NS) tissues were selected from 10 patients. The fibrosis-related proteins were detected via hematoxylin eosin (HE) staining, Masson staining and immunohistochemical detection. The relative expression difference of miR-564 in NS tissues and HS tissues was detected via reverse transcription-polymerase chain reaction (RT-PCR). The protein expression difference of transforming growth factor-β1 (TGF-β1) in NS tissues and HS tissues was detected via Western blotting. Moreover, the hypertrophic scar fibroblast (HSF) cells were isolated from HS tissues and divided into four groups according to different treatment methods: blank control group, scramble-transfected negative control group, miR-564 inhibitor-transfected miR-564 inhibitor group, and miR-564 plasmid-transfected miR-564 mimic group. The expressions of TGF-β1 in blank control group, scramble group, miR-21 mimic group and miR-21 inhibitor group were detected via RT-PCR and Western blotting.
RESULTS: MiR-564 was highly expressed in HSF cells. Compared with that of blank control group, the expression of TGF-β1 was down-regulated through inhibiting the miR-564 expression, thus inhibiting the activation and proliferation of HSF cells. However, the overexpression of miR-564 achieved the opposite results.
CONCLUSIONS: Up-regulated mir-564 promoted the development of hypertrophic scar via enhancing the expression of TGF-β1. MiR-564 may be a potential novel molecular target for the treatment of hypertrophic scarring.


KEY WORDS: Human miR564 - Transforming growth factor beta1 - Hypertrophic cicatrix - Fibroblasts - Cell proliferation

top of page